X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (86) 86
humans (83) 83
primary angioplasty (68) 68
aged (67) 67
female (67) 67
male (67) 67
middle aged (52) 52
coronary heart disease (42) 42
cardiac patients (40) 40
cardiac & cardiovascular systems (39) 39
risk factors (38) 38
elevation myocardial-infarction (37) 37
peripheral vascular disease (36) 36
cardiology (32) 32
cardiovascular (31) 31
percutaneous coronary intervention (31) 31
coronary artery disease (30) 30
mortality (30) 30
clopidogrel (28) 28
randomized-trials (28) 28
coronary angiography (27) 27
coronary artery disease - blood (27) 27
hematology (27) 27
metaanalysis (27) 27
analysis (25) 25
aged, 80 and over (22) 22
care and treatment (22) 22
platelet aggregation inhibitors - therapeutic use (22) 22
risk (22) 22
dual antiplatelet therapy (21) 21
ticagrelor (19) 19
transluminal angioplasty (18) 18
aspirin (17) 17
iib-iiia inhibitors (17) 17
myocardial-infarction (17) 17
ticlopidine - analogs & derivatives (17) 17
atherosclerosis (16) 16
coronary artery disease - diagnostic imaging (16) 16
intervention (16) 16
meta-analysis (16) 16
pharmacology & pharmacy (16) 16
treatment outcome (16) 16
acute coronary syndromes (15) 15
adenosine - analogs & derivatives (15) 15
artery-disease (15) 15
medical research (15) 15
odds ratio (15) 15
percutaneous coronary intervention - adverse effects (15) 15
platelet aggregation - drug effects (15) 15
stents (15) 15
aspirin - therapeutic use (14) 14
drug-eluting stents (14) 14
medicine, experimental (14) 14
blood platelets - drug effects (13) 13
cardiovascular-disease (13) 13
cohort studies (13) 13
diabetes (13) 13
internal medicine (13) 13
medicine & public health (13) 13
platelet aggregation (13) 13
prevalence (13) 13
acute coronary syndrome - drug therapy (12) 12
drug therapy, combination (12) 12
prasugrel (12) 12
prospective studies (12) 12
statins (12) 12
ticlopidine - therapeutic use (12) 12
acute coronary syndrome - blood (11) 11
biomarkers - blood (11) 11
cardiovascular disease (11) 11
coronary artery disease - epidemiology (11) 11
heart attacks (11) 11
platelet aggregation inhibitors - administration & dosage (11) 11
vitamin d (11) 11
adenosine - therapeutic use (10) 10
blood platelets - pathology (10) 10
chi-square distribution (10) 10
clinical-implications (10) 10
heart attack (10) 10
heart-disease (10) 10
italy - epidemiology (10) 10
platelet count (10) 10
therapy (10) 10
time factors (10) 10
acute coronary syndrome (9) 9
acute coronary syndrome - therapy (9) 9
angioplasty (9) 9
bare-metal stents (9) 9
coronary artery disease - drug therapy (9) 9
coronary vessels (9) 9
diabetes mellitus (9) 9
diabetics (9) 9
endocrinology & metabolism (9) 9
mean platelet volume (9) 9
myocardial infarction - therapy (9) 9
percutaneous coronary intervention - methods (9) 9
platelet aggregation inhibitors - adverse effects (9) 9
platelet function tests (9) 9
randomized controlled trials as topic (9) 9
activation (8) 8
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Spanish Journal of Cardiology (Revista Española de Cardiología, English Edition), ISSN 1885-5857, 2017, Volume 71, Issue 4, pp. 309 - 309
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 03/2019, Volume 73, Issue 9, pp. 49 - 49
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 11, pp. 1207 - 1207
  [...]DAPT provided a significant reduction in mortality and a slight benefit in stroke, with no increase in major bleedings, as compared to MAPT. 
Cardiovascular | Internal Medicine | Heart valve diseases | Analysis | Anticoagulants (Medicine) | Stroke | Mortality
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 11, pp. 215 - 215
  [...]the carriage of the G allele conditions the impact of hypovitaminosis D on the response to antiplatelet agents, with an increased occurrence of HRPR... 
Cardiovascular | Internal Medicine | Calcifediol | Genetic aspects | Alfacalcidol | Vitamin D | Protein binding | Vitamin deficiency | Genes | Polymorphism
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 03/2018, Volume 71, Issue 11, pp. A99 - A99
In particular, the newly introduced ADP-antagonist Ticagrelor, can provide a more potent and predictable platelet inhibition as compared to clopidogrel, and... 
Adenosine | Circulatory system | Multivariate analysis | Polymorphism
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 04/2016, Volume 67, Issue 13, p. 1173
  [...]the identification of schistocytes at blood stream, and the elevation of LDH (1079 U/L) with an aptoglobin consumption (7 mg/dl) and a negative Coombs... 
Coronary heart disease | Cardiovascular disease | Emergency medical care | Heart attacks | Acute coronary syndromes
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2016, Volume 67, Issue 13, pp. 2349 - 2349
  Conclusions In patients with CAD, the addition of a high-intensity statin treatment is associated to a significant increase in vitamin D levels and lower... 
Cardiovascular | Internal Medicine | Care and treatment | Vitamin D | Cardiac patients | Calcifediol | Dosage and administration | Alfacalcidol | Coronary heart disease | Statins | Heart attacks | Blood platelets | Coronary vessels | Cardiovascular disease | Acute coronary syndromes
Journal Article
Atherosclerosis, ISSN 0021-9150, 2012, Volume 222, Issue 2, pp. 426 - 433
Highlights ► Abciximab has been shown to improve survival in STEMI patients undergoing primary angioplasty. ► Intracoronary administration, by providing of... 
Cardiovascular | ST-elevation myocardial infarction | Primary angioplasty | Abciximab | MORTALITY | REVASCULARIZATION | CARDIAC & CARDIOVASCULAR SYSTEMS | IIB-IIIA INHIBITORS | REPERFUSION | PERCUTANEOUS CORONARY INTERVENTION | GLYCOPROTEIN IIB/IIIA | PERIPHERAL VASCULAR DISEASE | PERFUSION | BLOCKADE | ELEVATION MYOCARDIAL-INFARCTION | Myocardial Infarction - mortality | Injections, Intravenous | Humans | Immunoglobulin Fab Fragments - adverse effects | Antibodies, Monoclonal - adverse effects | Secondary Prevention | Coronary Vessels | Patient Selection | Angioplasty, Balloon, Coronary - adverse effects | Myocardial Infarction - therapy | Angioplasty, Balloon, Coronary - mortality | Time Factors | Platelet Aggregation Inhibitors - administration & dosage | Myocardial Infarction - physiopathology | Odds Ratio | Platelet Aggregation Inhibitors - adverse effects | Risk Assessment | Risk Factors | Treatment Outcome | Evidence-Based Medicine | Randomized Controlled Trials as Topic | Regression Analysis | Immunoglobulin Fab Fragments - administration & dosage | Antibodies, Monoclonal - administration & dosage | Coronary Circulation - drug effects | Hemorrhage - chemically induced | Infusions, Intravenous | Injections, Intra-Arterial | Angioplasty | Analysis | Cardiac patients | Atherosclerosis | Comparative analysis | Cardiology
Journal Article
Journal Article
Revista Espanola de Cardiologia, ISSN 0300-8932, 04/2018, Volume 71, Issue 4, p. 309
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2015, Volume 66, Issue 15, pp. B36 - B36
  Methods We performed formal searches of PubMed, EMBASE, Cochrane central register of controlled trials and major international scientific session abstracts... 
Cardiovascular | Internal Medicine | Care and treatment | Anticoagulants (Medicine) | Cardiac patients | Stent (Surgery) | Heart attacks | Transplants & implants | Angioplasty | Stents | Mortality
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2015, Volume 66, Issue 15, pp. B82 - B82
  [...]only few studies have assessed the role of CKD on response to dual antiplatelet therapy with conflicting results. [...]the aim of our study was to... 
Cardiovascular | Internal Medicine | Cardiovascular disease | Heart attacks | Blood platelets | Angina pectoris | Acute coronary syndromes | Coronary vessels
Journal Article
Atherosclerosis, ISSN 0021-9150, 05/2019, Volume 284, pp. 136 - 147
More potent antithrombotic strategies have significantly reduced the rate of recurrent ischemic events in cardiovascular disease. Ticagrelor, in particular,... 
Athrothrombosis | Ticagrelor | Mortality | Meta-analysis | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | ASPIRIN | STEMI PATIENTS | INTERVENTIONS | CLOPIDOGREL | DUAL ANTIPLATELET THERAPY | TASK-FORCE | ANTITHROMBOTIC THERAPY | PERIPHERAL VASCULAR DISEASE | PRIMARY ANGIOPLASTY | PLATELET REACTIVITY | Prevention | Analysis | Cardiology | Health aspects | Coronary heart disease
Journal Article
Cardiovascular Drugs and Therapy, ISSN 0920-3206, 2016, Volume 30, Issue 6, pp. 611 - 622
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2015, Volume 65, Issue 10, pp. A1747 - A1747
  V/CrCl>6.15 was more often associated with lower level of red blood cells and haemoglobin, lower total and LDL-cholesterol, but higher uric acid, glycaemia... 
Cardiovascular | Internal Medicine | Heart attacks | Medical imaging | Acute coronary syndromes | Multivariate analysis
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.